4//SEC Filing
Drechsler Andrew T 4
Accession 0001493152-18-016231
CIK 0001695357other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:00 PM ET
Size
7.1 KB
Accession
0001493152-18-016231
Insider Transaction Report
Form 4
Drechsler Andrew T
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-11-13$2.50/sh+10,000$25,000→ 16,250 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-11-13−10,000→ 531,720 totalExercise: $2.50Exp: 2027-09-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option was granted on September 11, 2017, pursuant to the Issuer's 2017 Equity Incentive Plan. 216,688 option shares vest in four equal annual installments commencing on September 1, 2018; the remaining 325,032 option shares vest upon completion of certain performance milestones. The completion of each milestone vests 15% of the total option shares.
Documents
Issuer
Provention Bio, Inc.
CIK 0001695357
Entity typeother
Related Parties
1- filerCIK 0001324734
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:00 PM ET
- Size
- 7.1 KB